Improving Bisphosphonate Use and Evaluation in a Rural Family Medicine Practice.


Journal

The Senior care pharmacist
ISSN: 2639-9636
Titre abrégé: Sr Care Pharm
Pays: United States
ID NLM: 101737969

Informations de publication

Date de publication:
01 Mar 2021
Historique:
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 28 4 2021
Statut: ppublish

Résumé

To evaluate the prevalence of bisphosphonate use without a drug holiday and to assess the success of an interdisciplinary approach to manage and discontinue bisphosphonate therapy. The study was completed at one rural family medicine center. The practice employs two fulltime pharmacists. Clinical pharmacists' responsibilities include chronic care management as well as collaboration with the team during interdisciplinary clinics. Clinical pharmacists frequently collaborate with other professionals on medication evaluations and quality improvement projects. The pharmacy team and medical resident collaborated to determine appropriateness of bisphosphonate use. This was a two-phase evaluation. In the first phase, therapies were evaluated based on duration and consistency with guideline recommendations based on a retrospective chart review. In the second phase, the pharmacy and medicine team determined if therapy warranted further continuation or if a drug holiday was needed. The team reached out to providers proactively and provided patient and provider education on discontinuing therapy. Patient demographics, bisphosphonate regimen and duration of prescription, frequency of drug holidays, and success rate of therapy discontinuation. Bisphosphonates were prescribed for an average of 4.2 years with 56 patients prescribed therapy for >5 years. Twenty-one of the 56 patients had a history of a drug holiday, and 13 of the 35 remaining patients had therapy discontinued or a drug holiday was initiated based on the team's recommendation. Patients were more likely to be prescribed therapy for >5 years if they were older and had more provider appointments.

Identifiants

pubmed: 33662239
doi: 10.4140/TCP.n.2021.152
doi:

Substances chimiques

Diphosphonates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-158

Auteurs

Megan Adelman (M)

West Virginia University School of Pharmacy, West Virginia University Medicine Department of Family Medicine, Morgantown, West Virginia.

Shauna Assadzandi (S)

West Virginia University School of Pharmacy, West Virginia University Medicine Department of Family Medicine, Morgantown, West Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH